Jiangsu Qianren Biotechnology Co., Ltd. is an emerging comprehensive pharmaceutical enterprise integrating R&D, production and sales.
We focus on orthopedic, endocrine, cardiovascular & cerebrovascular, respiratory, anti-tumor and anti-diabetic drugs. Our self-developed drugs adopt cutting-edge sustained and controlled release technologies. Key raw materials and preparations hold independent intellectual property rights, supporting our solid technical competitiveness.
With a total investment of about RMB 300 million, our factory deploys internationally advanced facilities and automatic control systems for main production lines. We run an in-house pharmaceutical research center in collaboration with top domestic universities, with over 100 R&D staff including PhD and master holders. Backed by internal innovation and partnerships with research institutes, our innovation system keeps maturing and strengthens our competitive edge in China’s pharmaceutical sector.
